These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2626743)

  • 1. How high is the true fibrinogen content of fibrinogen standards?
    Furlan M; Felix R; Escher N; Lämmle B
    Thromb Res; 1989 Dec; 56(5):583-92. PubMed ID: 2626743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of freeze-drying on the clotting properties of fibrinogen in plasma.
    Jensen T; Halvorsen S; Godal HC; Skjønsberg OH
    Thromb Res; 2002 Mar; 105(6):499-502. PubMed ID: 12091049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of a purified fibrinogen calibration material for Clauss method and turbidimetric immunoassay possessing biological activity and antigenicity.
    Okuda M; Uemura Y; Naka K; Tatsumi N
    Clin Lab Haematol; 2003 Jun; 25(3):167-72. PubMed ID: 12755793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples.
    van den Besselaar AMHP; van Rijn CJJ; Cobbaert CM; Reijnierse GLA; Hollestelle MJ; Niessen RWLM; Hudig F
    Clin Chem Lab Med; 2017 Oct; 55(11):1761-1769. PubMed ID: 28412717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio.
    Palareti G; Maccaferri M; Manotti C; Tripodi A; Chantarangkul V; Rodeghiero F; Ruggeri M; Mannucci PM
    Clin Chem; 1991 May; 37(5):714-9. PubMed ID: 2032326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of fibrinogen degradation in rat anaphylaxis.
    Fésüs L; Muszbek L; Csaba B
    Int Arch Allergy Appl Immunol; 1975; 49(4):540-7. PubMed ID: 1158526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
    Lipinski B; Lipinska I
    Magnes Res; 2000 Dec; 13(4):233-7. PubMed ID: 11153893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Fibrinogen and Thrombin Time (TT).
    Undas A
    Methods Mol Biol; 2017; 1646():105-110. PubMed ID: 28804822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical structure and properties of duck and goose fibrinogen.
    Krajewski T; Nowak P; Cierniewski CS
    Biochim Biophys Acta; 1980 Mar; 622(1):94-104. PubMed ID: 6153910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Adelaide: a familial hypodysfibrinogenaemia associated with abnormal alpha chains.
    Exner T; Barber S; Sage RE; Kronenberg H
    Br J Haematol; 1984 Jan; 56(1):95-106. PubMed ID: 6704329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New method for determining thrombin-clottable fibrinogen.
    Frigola A; Angeloni S; Cerqueti AR
    Clin Chem; 1977 Nov; 23(11):2103-6. PubMed ID: 912875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study of a proposed international standard for plasma fibrinogen measurement.
    Gaffney PJ; Wong MY
    Thromb Haemost; 1992 Oct; 68(4):428-32. PubMed ID: 1448775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative abnormality of an Aalpha chain molecular weight form in the fibrinogen of cirrhotic patients.
    Weinstein MJ; Deykin D
    Br J Haematol; 1978 Dec; 40(4):617-30. PubMed ID: 728374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.